HMPC
Mojisola Adeyeye: NAFDAC committed to supporting coronavirus treatment initiatives
The National Agency for Food and Drug Administration and Control (NAFDAC) says it is committed to supporting any intervention aimed at facilitating the treatment of the COVID-19. The Director General of the agency, Prof. Mojisola Adeyeye, said this in a statement in Abuja on Thursday. According to Adeyeye, part of the efforts to advance herbal products development for the treatment of COVID-19 informed the setting up of the Nigerian Herbal Medicine Product Committee (HMPC). She said that the platform had brought together manufacturers, academics, researchers and relevant stakeholders by bridging the gap created between traditional medicine practitioners and drug manufacturers. “This collaboration brokered by the agency aims at translating research of herbs into products of commerce with pr...
NAFDAC explains position on claims for coronavirus remedies
The National Agency for Food and Drug Administration and Control (NAFDAC) has said that the rush to mitigate the mortality and morbidly resulting from the COVID-19 pandemic has resulted in acceleration of product development, repurposing of formulations, off label use of therapeutics and the search for a vaccine to prevent COVID-19. The agency however noted that it has only received application from one company for a product the company is presenting (for approval) to the Agency for the treatment of the symptoms of Covid-19, and not for the cure of Covid-19 as a disease. In a statement yesterday in Abuja, Director General of NAFDAC, Prof Mojisola Christianah Adeyeye stated that in a bid to discover a cure for Covid-19 disease, the public has witnessed quite a number of claims from differen...
